Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence

Patricia Ormiga,1 Claudia A Hernández,2 Rogério de Lima Romeiro,3 Aude Bernardin,4 Fabio Sambatti Crema,5 Lauren Nakab,6 Lital Shklanovsky,7 Graeme Kerson8 1Clínica Patricia Ormiga, Rio de Janeiro, Brazil; 2CH Dermatologia, Medellin, Antioquia, Colombia; 3Faculdade São Leopoldo Mandic, Instituto São...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical, cosmetic and investigational dermatology cosmetic and investigational dermatology, 2024-01, Vol.17, p.2533-2536
Hauptverfasser: Ormiga, Patricia, Hernández, Claudia A, de Lima Romeiro, Rogério, Bernardin, Aude, Sambatti Crema, Fabio, Nakab, Lauren, Shklanovsky, Lital, Kerson, Graeme
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patricia Ormiga,1 Claudia A Hernández,2 Rogério de Lima Romeiro,3 Aude Bernardin,4 Fabio Sambatti Crema,5 Lauren Nakab,6 Lital Shklanovsky,7 Graeme Kerson8 1Clínica Patricia Ormiga, Rio de Janeiro, Brazil; 2CH Dermatologia, Medellin, Antioquia, Colombia; 3Faculdade São Leopoldo Mandic, Instituto São Leopoldo Mandic, Área de Harmonização Orofacial, São Paulo, Brazil; 4Allergan Aesthetics, an AbbVie company, Pringy, France; 5Allergan Aesthetics, an AbbVie company, São Paulo, Brazil; 6Allergan Aesthetics, an AbbVie company, Irvine, CA, USA; 7Allergan Aesthetics, an AbbVie company, Lod, Israel; 8Allergan Aesthetics, an AbbVie company, Marlow, UKCorrespondence: Patricia Ormiga, Clínica Patricia Ormiga, Av. Ataulfo de Paiva, 204 – Sala 908, Leblon, Rio de Janeiro, Brazil, Tel +21 98805-1848, Email paormiga@gmail.com
ISSN:1178-7015
1178-7015
DOI:10.2147/CCID.S474587